Pfizer drug filings on track despite setbacks
LONDON (Reuters) - It's been a bad month for Pfizer's <PFE.N> research labs but its head of R&D says the world's biggest drugmaker is on track to hit earlier targets for new drug filings despite the setbacks. "We have had some disappointments, ...
